Methicillin resistant staphylococcus aureus screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
== Overview == | |||
The National Committee for Clinical Laboratory Standards (NCCLS), now called the Clinical and Laboratory Standards Institute (CLSI), recommends the [[cefoxitin]] disk screen test, the [[latex agglutination test]] for PBP2a, or a plate containing 6 μg/ml of [[oxacillin]] in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) as alternative methods of testing for MRSA. For methods of inoculation, see CLSI Approved Standard M100-S15. | The National Committee for Clinical Laboratory Standards (NCCLS), now called the Clinical and Laboratory Standards Institute (CLSI), recommends the [[cefoxitin]] disk screen test, the [[latex agglutination test]] for PBP2a, or a plate containing 6 μg/ml of [[oxacillin]] in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) as alternative methods of testing for MRSA. For methods of inoculation, see CLSI Approved Standard M100-S15. | ||
| Line 13: | Line 15: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs | [[Category:Needs content]] | ||
Revision as of 19:36, 11 December 2012
|
Methicillin resistant staphylococcus aureus infections Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Methicillin resistant staphylococcus aureus screening On the Web |
|
American Roentgen Ray Society Images of Methicillin resistant staphylococcus aureus screening |
|
FDA on Methicillin resistant staphylococcus aureus screening |
|
CDC on Methicillin resistant staphylococcus aureus screening |
|
Methicillin resistant staphylococcus aureus screening in the news |
|
Blogs on Methicillin resistant staphylococcus aureus screening |
|
Directions to Hospitals Treating Methicillin resistant staphylococcus aureus |
|
Risk calculators and risk factors for Methicillin resistant staphylococcus aureus screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
The National Committee for Clinical Laboratory Standards (NCCLS), now called the Clinical and Laboratory Standards Institute (CLSI), recommends the cefoxitin disk screen test, the latex agglutination test for PBP2a, or a plate containing 6 μg/ml of oxacillin in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) as alternative methods of testing for MRSA. For methods of inoculation, see CLSI Approved Standard M100-S15.